What did @thatsarajane actually say?
She described her first month on Mounjaro as largely positive and uneventful. "Food noise was gone," she said, and she experienced no significant side effects beyond thirst. She also admitted to struggling to eat enough because not being hungry felt so novel. Her closing line was that "starting at anything never scary, but being trapped is scarier." No miracle claims. No medical advice. Just a personal account.
That framing matters. She was not telling anyone to take Mounjaro. She was describing what happened to her. The video is anecdote, not instruction. That distinction is important before we get into what the science actually says about her experience.
Does the science back this up?
Mostly, yes, with one significant caveat about side effects. The "food noise" reduction she describes is one of the more consistently reported and studied effects of GLP-1 and GIP/GLP-1 dual agonists. The near-zero appetite response she experienced tracks with the clinical data.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found tirzepatide, the active ingredient in Mounjaro, produced significant appetite suppression and reduced caloric intake in participants with obesity. Qualitative research has backed up the "food noise" language specifically. Mϕller et al. (2022, Diabetes, Obesity and Metabolism) documented that GLP-1 receptor agonists reduce preoccupation with food as a distinct psychological effect, not just reduced hunger. So when she says she stopped lying in bed thinking about toast and biscuits, that is a real, documented pharmacological effect, not placebo.
The thirst she mentions is also plausible. Tirzepatide can affect fluid balance, and increased water intake is a commonly self-reported behavior change, though it is not a formally listed adverse effect in the prescribing information.
What did they get wrong (or right)?
The side effect claim is where this gets complicated. Saying she had "no bad side effects whatsoever" is her honest experience, but it is statistically unusual, and presenting it without context could set unrealistic expectations for viewers.
In SURMOUNT-1, gastrointestinal side effects affected a majority of participants at the 5mg and 10mg dose levels. Nausea was reported in roughly 30 percent of participants at the lower dose and climbed higher with dose escalation. Vomiting, diarrhea, and constipation were also common. Her experience is real. It is just not typical, especially at higher doses or during titration. Calling it "no bad side effects whatsoever" as a general take rather than a personal one is the one place this video could genuinely mislead someone.
What she got right: the framing around mental headspace and the psychological weight of food obsession is clinically underappreciated. Researchers like Tronieri et al. (2023, Obesity Reviews) have argued that the cognitive and psychological burden of chronic food preoccupation is a legitimate treatment outcome that trial endpoints often fail to capture. She named something real.
What should you actually know?
A few things are worth being clear about if you are watching this video and considering Mounjaro or any GLP-1 based medication.
- Tirzepatide is approved in the US and UK for type 2 diabetes (as Mounjaro) and weight management (as Zepbound in the US). It is a prescription medication. A licensed prescriber needs to evaluate whether it is appropriate for you.
- Side effects are common. The clinical trial data is unambiguous on this. A side-effect-free first month happens, but it is the exception, not the rule. Prepare for the possibility of nausea, particularly during dose increases.
- The under-eating she describes is a real risk. Not eating enough while on tirzepatide can result in muscle loss. Adequate protein intake and medical supervision during the medication are not optional extras.
- Compounded tirzepatide is not the same as FDA-approved Mounjaro or Zepbound. If you are being offered a compounded version, ask direct questions about sourcing and oversight.
- One month is a short window. Long-term outcomes, including what happens if you stop the medication, are a separate and important conversation to have with your prescriber.
Bottom line
This is a good-faith personal account that gets more right than wrong. The food noise reduction is real. The mental health angle is legitimate and underreported. The side effect experience is genuine but atypical enough that it should carry a bigger asterisk than she gave it. She is not selling anything. She is not prescribing anything. She is just telling her story, which is fine, as long as viewers remember that her story is one data point.